Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by newdaydawningon Jan 19, 2021 5:12pm
255 Views
Post# 32329473

Virginia is a big catch basin for Ph2 participants

Virginia is a big catch basin for Ph2 participantsWhen you add Virginia's population to that of North Carolina, DC and Maryland, we are talking more than 27 million people. Out of that bunch, there are bound to be plenty of candidates for Ph2.

As for other US sites close to onboarding, I expect the following:

Given that TLT already has connections with the University of Iowa (Michael O'Donnell), we could see that site service the US mid-west.

As for the great state of Texas and its 29M inhabitants, we have Ashish Kamat on board at the MD Anderson Cancer Centre in Houston.

Overall, between Canada and the US, I see trial enrolment numbers jumping substantially in Q2.




<< Previous
Bullboard Posts
Next >>